Common Contracts
19 similar Severance Agreement contracts by Immunogen Inc
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2010 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Craig Barrows (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2010 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Peter Williams (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2010 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and John M. Lambert (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2010 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Gregory D. Perry (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2010 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and James J. O’Leary (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2010 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Daniel M. Junius (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2011 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 18th day of January, 2011 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”), and Theresa Wingrove, Ph.D. (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • January 29th, 2010 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 17th day of December, 2009 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Suzanne Cadden (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • August 28th, 2009 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 17th day of August, 2009 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Peter Williams (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 6th, 2009 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 9th day of January, 2009 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Gregory D. Perry (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 6th, 2009 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2008 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Mitchel Sayare, Ph.D. (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 6th, 2009 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2008 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Daniel M. Junius (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 6th, 2009 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2008 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and John M. Lambert, Ph.D. (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 6th, 2009 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 1st day of December, 2008 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and James J. O’Leary, M.D. (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 7th, 2008 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 27th day of November, 2007 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and John A. Tagliamonte (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2007 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2006 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Mitchel Sayare (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2007 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2006 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Walter A. Blattler, Ph.D. (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2007 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2006 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and John M. Lambert, Ph.D. (the “Executive”).
SEVERANCE AGREEMENTSeverance Agreement • February 8th, 2007 • Immunogen Inc • Pharmaceutical preparations • Massachusetts
This Agreement is entered into as of the 30th day of November, 2006 (the “Effective Date”) by and between ImmunoGen, Inc., a Massachusetts corporation (the “Company”) and Daniel M. Junius (the “Executive”).
